Lomitapide Observational Worldwide Evaluation Registry

Trial Profile

Lomitapide Observational Worldwide Evaluation Registry

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 16 Nov 2016

At a glance

  • Drugs Lomitapide (Primary)
  • Indications Hypercholesterolaemia
  • Focus Adverse reactions
  • Acronyms LOWER
  • Sponsors Aegerion Pharmaceuticals
  • Most Recent Events

    • 16 Nov 2016 Results (n=143, data cut off: March 2016) presented at the 89th Annual Scientific Sessions of the American Heart Association
    • 10 Nov 2015 Results were poster presented at the American Heart Associations (AHA) Scientific Sessions 2015.
    • 10 Nov 2015 Results of 84 patients enrolled till March 2015 were published in an Aegerion Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top